# Protenus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/protenus

- Industry: IT Security/Cybersecurity
- Headquarters: Baltimore, US
- Website: www.protenus.com
- Total disclosed funding: $51M
- Latest round: Series D (Apr 27, 2021)
- Investors on record: 12

## About

Protenus, Inc. is a healthcare analytics company that specializes in protecting patient privacy through advanced data analytics and surveillance solutions. The firm aims to enhance operational integrity within healthcare organizations.Founded in 2014, Protenus, Inc. operates from Baltimore, US, focusing on providing data-driven solutions to healthcare institutions. The company was acquired in January 2025 by Bluesight, Inc., which is a portfolio company of Thoma Bravo and New Leaf Venture Partners. Nick Culbertson, the founder and CEO, has a background in healthcare analytics, further driving the company's vision.Protenus offers integrated solutions tailored for hospitals and healthcare systems, focusing on patient privacy monitoring, medication management, and compliance auditing. Their key offerings include PrivacyPro, which monitors patient privacy violations, and various analytics tools that help healthcare organizations streamline operations and enhance compliance.Protenus generates revenue through a subscription-based model, engaging clients under annual contracts for software access. The offerings are crucial for healthcare organizations aiming to optimize drug expenditures and improve operational efficiency, reflecting their essential role in client operations.Following its acquisition by Bluesight, Inc. in January 2025, Protenus plans to expand its platform capabilities. The latest funding from this acquisition is expected to support the development of new products and enhancements to existing services. Protenus aims to penetrate new geographic markets, particularly within the United States, to broaden its client base and improve operational efficiencies within healthcare institutions.

## Funding rounds

- Series D, Apr 27, 2021, $16M — F-Prime Capital, Kaiser Permanente Ventures, MemorialCare Innovation Fund, Arthur Ventures, LionBird, Allumia Ventures, Transformation Capital, Gaingels
- Series C, Aug 16, 2019, $17M — F-Prime Capital, Kaiser Permanente Ventures, Arthur Ventures, LionBird, Allumia Ventures, Transformation Capital
- Series B, Jan 22, 2018, $11M — F-Prime Capital, Kaiser Permanente Ventures, Arthur Ventures, LionBird, Cognosante
- Series A, Jul 19, 2017, $3M — F-Prime Capital, Kaiser Permanente Ventures, LionBird
- Series A, Feb 17, 2016, $4M — DreamIt Ventures, TCP Venture Capital, Arthur Ventures, Baltimore Angels, LionBird, Cognosante
- Seed, Jan 7, 2015, $0.1M — TCP Venture Capital
- Seed, Jan 10, 2014 — DreamIt Ventures

## Investors

- DreamIt Ventures (https://capitalatlas.ai/funds/dreamit-ventures) — Seed, Series A
- TCP Venture Capital (https://capitalatlas.ai/funds/tcp-venture-capital) — Seed, Series A
- Arthur Ventures (https://capitalatlas.ai/funds/arthur-ventures) — Series A, Series B, Series C, Series D
- Baltimore Angels — Series A
- LionBird (https://capitalatlas.ai/funds/lionbird) — Series A, Series B, Series C, Series D
- Cognosante — Series A, Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B, Series C, Series D
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series A, Series B, Series C, Series D
- Allumia Ventures (https://capitalatlas.ai/funds/allumia-ventures) — Series C, Series D
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series C, Series D
- MemorialCare Innovation Fund (https://capitalatlas.ai/funds/memorialcare-innovation-fund) — Series D
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series D